Rama Vision (523289)
Fast GrowerScore breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹86.81 |
| Market Cap | ₹90.51 Cr |
| P/E Ratio | 25.18 |
| ROCE | 12.34% |
| ROE | 17.3% |
| Dividend Yield | 0% |
| Profit Growth | 492.68% |
| Debt/Equity | — |
| Sales Growth | 42.33% |
| 52-Week Range | ₹79.09 — ₹190.85 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹29.54 |
Strengths
- Sales growth of 42.33% and latest quarterly profit of ₹2 Cr indicate strong recent momentum.
- Piotroski F-Score of 7/9 suggests improving financial health across profitability, leverage, and efficiency.
- ROE of 17.30% is respectable for a small-cap company.
- PEG of 0.09 implies the current P/E is low relative to the recent earnings growth rate.
- Stock is roughly 55% below its 52-week high of ₹190.85, providing a cheaper entry than earlier.
Concerns
- Trading and distribution businesses generally lack pricing power and sustainable moats.
- P/E of 25.18 and P/B of 2.94 offer limited margin of safety for a small-cap trader.
- Profit growth of 492.68% is flattered by a low base; extrapolating the latest quarter's ₹2 Cr profit is risky.
- No debt/equity data, promoter holding, or dividend (0.00%) leaves valuation and governance unclear.
AI Analysis
At ₹86.81, Rama Vision sells at ₹91 crore market cap, 25.18 times trailing earnings and 2.94 times book value. For a trading and distribution company, that is not a Benjamin Graham bargain. Book value is only ₹29.54; I am paying nearly three rupees for every rupee of net assets. The recent quarter does catch my eye: ₹42 crore sales and ₹2 crore profit, which annualizes to roughly ₹8 crore profit and a much lower forward multiple. But one quarter is not a franchise. Profit growth of 492% sounds spectacular until you remember it comes off a tiny base; Graham would call that a statistical illusion. Sales growth of 42% is real, but in distribution, growth often buys its way in with thin margins and little pricing power. ROE of 17.3% is decent, but ROCE of 12.34% is ordinary; the gap suggests the company is not creating exceptional value per rupee of capital. The Piotroski score of 7/9 is encouraging and points to improving balance-sheet health, yet the score is only a starting point. I have no debt-to-equity data, no promoter holding figures, and the FairStock score says insufficient data. I cannot trust what I cannot see. The stock has collapsed from ₹190.85 to ₹86.81, though still above the 52-week low of ₹74.00; that smell of opportunity can also be the smell of a value trap. No dividend means my return depends entirely on the business reinvesting profitably. I would want a much wider margin of safety, or proof that growth is durable, before putting my money beside this one.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer